BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs7903146
,
DRD2
,
calcium channel activity
,
Leukemia
,
Pancreas
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Bicalutamide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
AR
NKX3-1
DLX5
PMEPA1
CYP2A7
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
organic cyclic compound binding
heterocyclic compound binding
nucleoplasm
FISCHER_DREAM_TARGETS
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Prostate cancer cell lines treated with BET domain inhibitors
Prostate cancer LnCaP cells treated with bicalutamide, 17-AAG or SAHA
Prostate cancer LAPC-4 cells treated with 28 different androgen-modulators
Prostate adenocarcinoma LNCaP cells with NCOR1 siRNA knockdown treated with casodex
Castration-resistant prostate cancer response to different chemotherapeutics
Explore Curated Studies Results
Literature
Most Relevant Literature
A study of plasma bicalutamide concentrations in hemodialysis patients.
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP …
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
Development and validation of stability-indicating HPLC and UPLC methods for the determination of bi…
Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ribociclib and Bicalutamide in AR+ TNBC
Camostat With Bicalutamide for COVID-19
Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer
AR-inhibitor Bicalutamide in Treating Patients With TNBC
Bicalutamide in Treating Patients With Metastatic Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ